I’ve recently communicated with Validcare and their liver safety study is going very well They are closing in on 1000 participants and expect to conclude the study within the next few weeks Before Covid-19 hit, they had planned on starting the study in March and ending it in June So everything got pushed back 4-5 months due to the pandemic The FDA already knows that CBD Isolate at low doses (under 70 mg/day) is safe to ingest, due to all the research that GW Pharma has performed So the new information this study will provide the FDA is whether adding other cannabinoids to CBD will be harmful to the liver I haven’t spoken with anybody who believes that the low doses regularly taken by CBD users (10-50 mg) cause any issues with liver function But it will be very good to finally have evidence from over a dozen CBD products in a well-designed study Sleek